Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "RNA"

2352 News Found

Moderna finalizes plan for long-term strategic partnership with Canada
Biotech | May 01, 2022

Moderna finalizes plan for long-term strategic partnership with Canada

Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually


Moderna files for authorization of its Covid-19 vaccine in young children six months to six years
Biotech | April 29, 2022

Moderna files for authorization of its Covid-19 vaccine in young children six months to six years

Submission to regulators globally is based on phase 2/3 studies of mRNA-1273 in young children


Dr Vijay Shetty creates an alternative to x-ray examination
News | April 28, 2022

Dr Vijay Shetty creates an alternative to x-ray examination

The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated


Ross Prize awarded to mRNA technology, Covid-19 vaccine innovators
News | April 28, 2022

Ross Prize awarded to mRNA technology, Covid-19 vaccine innovators

University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines


Differentiation based on innovation is the way forward: S Aparna
News | April 26, 2022

Differentiation based on innovation is the way forward: S Aparna

Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'


‘DREAM-ND’ and ‘DREAM-D’ Phase 3 trials of Desidustat published in American Journal of Nephrology
Biotech | April 25, 2022

‘DREAM-ND’ and ‘DREAM-D’ Phase 3 trials of Desidustat published in American Journal of Nephrology

Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia


Merck announces Joseph Romanelli will lead Merck Human Health International
News | April 21, 2022

Merck announces Joseph Romanelli will lead Merck Human Health International

In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S


Jorge Gomez joins Moderna as Chief Financial Officer
People | April 12, 2022

Jorge Gomez joins Moderna as Chief Financial Officer

Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019


Wacker, CordenPharma to produce mRNA vaccines for Germany
News | April 12, 2022

Wacker, CordenPharma to produce mRNA vaccines for Germany

Both companies have been selected for stand-by production by German government


Moderna kickstarts Phase 1/2 study for influenza vaccine candidate
Biotech | April 11, 2022

Moderna kickstarts Phase 1/2 study for influenza vaccine candidate

Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle